The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care

Obstetrics and Gynecology ◽

10.1097/aog.0000000000004524 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Audrey M. Burlando ◽

Anne N. Flynn ◽

Sarah Gutman ◽

Arden McAllister ◽

Andrea H. Roe ◽

...

Keyword(s):

Medroxyprogesterone Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-20-1355 ◽

2021 ◽

pp. cebp.EPI-20-1355-E.2020

Author(s):

Minh Tung Phung ◽

Alice W. Lee ◽

Anna H. Wu ◽

Andrew Berchuck ◽

Kathleen R. Cho ◽

...

Keyword(s):

Ovarian Cancer ◽

Medroxyprogesterone Acetate ◽

Protective Role ◽

Depot Medroxyprogesterone Acetate

Download Full-text

The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study

Contraception ◽

10.1016/j.contraception.2016.05.006 ◽

2016 ◽

Vol 94 (4) ◽

pp. 314-320 ◽

Author(s):

Irina Kaplan ◽

Douglas Ross ◽

Fiona Hilton ◽

Diana Morgenstern ◽

Kevin Wolter

Keyword(s):

Medroxyprogesterone Acetate ◽

Usability Study ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Role of transvaginal Doppler sonography in cases of irregular uterine bleeding with depot medroxyprogesterone acetate

Menoufia Medical Journal ◽

10.4103/mmj.mmj_237_18 ◽

2019 ◽

Vol 32 (4) ◽

pp. 1355

Author(s):

MohammedWahid Al-Sarag ◽

Medhat Essam ◽

Alaa Alhalabi ◽

Haitham Hamza

Keyword(s):

Medroxyprogesterone Acetate ◽

Doppler Sonography ◽

Uterine Bleeding ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Author Response ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate ◽

Download Full-text

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Medroxyprogesterone Acetate ◽

Bone Health ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.496155 ◽

2006 ◽

Author(s):

David Hubacher

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.486922 ◽

2006 ◽

Author(s):

Kate Curtis

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727748411.793536806 ◽

2017 ◽

Author(s):

Phillip Hay

Keyword(s):

Oral Contraceptives ◽

Medroxyprogesterone Acetate ◽

Vaginal Microbiome ◽

Combined Oral Contraceptives ◽

Depot Medroxyprogesterone Acetate

Download Full-text

A semi‐mechanistic pharmacokinetic model for depot medroxyprogesterone acetate and drug‐drug interactions with antiretroviral and antituberculosis treatment.

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2324 ◽

2021 ◽

Author(s):

Jose Francis ◽

Rosie Mngqibisa ◽

Helen McIlleron ◽

Michelle A Kendall ◽

Xingye Wu ◽

...

Keyword(s):

Drug Interactions ◽

Medroxyprogesterone Acetate ◽

Pharmacokinetic Model ◽

Depot Medroxyprogesterone Acetate ◽

Antituberculosis Treatment

Download Full-text

Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of dosing interval. Smit J, Botha J, McFadyen L, et al. Contraception 2004; 69: 3–7

Journal of Family Planning and Reproductive Health Care ◽

10.1783/1471189041261537 ◽

2004 ◽

Vol 30 (3) ◽

pp. 198-198

Author(s):

Judy Murty

Keyword(s):

Medroxyprogesterone Acetate ◽

Dosing Interval ◽

Depot Medroxyprogesterone Acetate

Download Full-text